This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Rosiglitazone exerts an anti-depressive effect in unpredictable chronic mild-stress-induced depressive mice by maintaining essential neuron autophagy and inhibiting excessive astrocytic apoptosis
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsTryptophan and brain disorders · Diet, Metabolism, and Disease · Adipose Tissue and Metabolism
The journal retracts the September 14th 2017 article cited above.
Following publication, the authors contacted the Editorial Office to request the retraction of the cited article, stating that there were errors in the figures. An investigation was conducted in accordance with Frontiers' policies, and confirmed image duplication in Figures 4, 5, 6, 7 and 8. The authors were unable to provide the raw data. Given the concerns about the validity of the data, and the lack of raw data, the editors no longer have confidence in the findings presented in the article. Therefore, the article has been retracted.
This retraction was approved by the Chief Executive Editor of Frontiers. The authors agree to this retraction.